Arkema SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Arkema SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C0803
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Arkema SA – Strategy, SWOT and Corporate Finance Report
Summary

Arkema SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Arkema SA (Arkema or ‘the company’) is engaged in the manufacturing and supplying of chemical products. The company provides biobased materials, composites, coatings, adhesives, health care and sports equipment solutions. It operates across Europe, Asia Pacific, Africa and the Middle East, and the Americas. Arkema is headquartered in Colombes, France.

Scope

- Detailed information on Arkema SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Arkema SA in the form of a SWOT analysis
- An in-depth view of the business model of Arkema SA including a breakdown and examination of key business segments
- Intelligence on Arkema SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Arkema SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Arkema SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Arkema SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Arkema SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Arkema SA: Company Overview 9
Arkema SA: Overview and Key Facts 9
Arkema SA: Overview 9
Arkema SA: Key Facts 9
Arkema SA: Key Employees 10
Arkema SA: Key Employee Biographies 12
Arkema SA: Major Products and Services 16
Arkema SA: Company History 18
Arkema SA: Management Statement 23
Arkema SA: Locations and Subsidiaries 25
Arkema SA: Key Competitors 26
Arkema SA: Company Analysis 27
Arkema SA: Business Description 27
Arkema SA: SWOT Analysis 29
Arkema SA: SWOT Overview 29
Arkema SA: Strengths 29
Arkema SA: Weaknesses 30
Arkema SA: Opportunities 31
Arkema SA: Threats 31
Arkema SA: Corporate Financial Deals Activity 33
Arkema SA: Financial Deals Overview 33
Arkema SA: Targets and Partners 34
Arkema SA: Top Deals 2014 – 2018YTD* 35
Arkema SA: Advisors 36
Arkema SA: Top Legal Advisors 36
Arkema SA: Mergers and Acquisitions 37
Arkema SA: Divestments 38
Arkema SA: Recent Developments 39
Arkema SA: News and Events Summary 39
Arkema SA: Business Expansion 42
Arkema SA: Contracts 43
Arkema SA: Corporate Governance 44
Arkema SA: Financial Performance 44
Arkema SA: Strategy and Operations 45
Appendix 46
Contact Us 46
Methodology 46
About MarketLine 47

List of Tables
Table 1: Arkema SA: Key Facts
Table 2: Arkema SA: Key Employees
Table 3: Arkema SA: Locations and Subsidiaries
Table 4: Arkema SA: Key Competitors
Table 5: Arkema SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Arkema SA: M&A Average Deal Size - Value (US$m)
Table 7: Arkema SA: Targets and Partners
Table 8: Arkema SA: Top Deals 2014 - 2018YTD*
Table 9: Arkema SA: Legal Advisor Ranking by Value (US$m)
Table 10: Arkema SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Arkema SA: M&A Activity by Geography (2014 - YTD*2018)
Table 12: Arkema SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 13: Arkema SA: News and Events Summary
Table 14: Arkema SA: Business Expansion
Table 15: Arkema SA: Contracts
Table 16: Arkema SA: Corporate Governance
Table 17: Arkema SA: Financial Performance
Table 18: Arkema SA: Strategy and Operations

List of Figures
Figure 1: Arkema SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Arkema SA: M&A Average Deal Size - Value (US$m)
Figure 3: Arkema SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Arkema SA: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Arkema SA: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Arkema SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pan American Silver Corp:企業の戦略・SWOT・財務分析
    Pan American Silver Corp - Strategy, SWOT and Corporate Finance Report Summary Pan American Silver Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Intelsat S.A. (I):企業の財務・戦略的SWOT分析
    Intelsat S.A. (I) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hudbay Minerals Inc:企業の戦略・SWOT・財務分析
    Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Exide Technologies:企業の戦略的SWOT分析
    Exide Technologies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Lamellar Biomedical Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Lamellar Biomedical Ltd (Lamellar Biomedical) is a biotechnology company that develops medical products using based on mimetics of extra-alveolar lamellar bodies. The company develops products using its proprietary Lamellasome technology that are mimetics of native extra-alveolar lamellar th …
  • AB Volvo:戦略・SWOT・企業財務分析
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Wockhardt Ltd (WOCKPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Wockhardt Ltd (Wockhardt) is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant bio-pharmaceutical formulations. The company's product portfolio caters to various therapeutic areas including orthopedics, dental c …
  • Damac Real Estate Development Ltd:企業の戦略・SWOT・財務分析
    Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Hatch Ltd:企業の戦略的SWOT分析
    Hatch Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Lietuvos energijos gamyba, AB (LNR1L)-エネルギー分野:企業M&A・提携分析
    Summary Lietuvos energijos gamyba, AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company tra …
  • Environmental Tectonics Corp:企業の戦略・SWOT・財務分析
    Environmental Tectonics Corp - Strategy, SWOT and Corporate Finance Report Summary Environmental Tectonics Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Pivotal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pivotal Therapeutics Inc (Pivotal Therapeutics) is a pharmaceutical company that develops and markets Omega-3 based therapies and therapeutic products for cardiovascular disorders. The company offers products such as VASCAZEN, a medical food formulated for the dietary management of an Omega- …
  • Gfk SE (GFK):企業の財務・戦略的SWOT分析
    Summary GfK SE (GfK) is a business service provider that offers market and consumer services. The company provides solutions such as online pricing intelligence, brand and customer experience, point of sales analytics, digital marketing intelligence, consumer panels, product catalogs, market opportu …
  • Ontario Power Generation Inc.:企業の戦略・SWOT・財務情報
    Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report Summary Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Innovation Pharmaceuticals Inc (IPIX)-製薬・医療分野:企業M&A・提携分析
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp is a biopharmaceutical company that offers discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company offers kevetrin for t …
  • Neurovance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neurovance Inc (Neurovance) is a clinical stage neuroscience focused company that develops centanafadine (CTN) SR for adult and pediatric Attention Deficit Hyperactivity Disorder (ADHD). CTN, formerly EB-1020, is a novel triple reuptake inhibitor that acts as a functional hybrid with activit …
  • The Nippon Synthetic Chemical Industry Co Ltd:企業の戦略的SWOT分析
    The Nippon Synthetic Chemical Industry Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Nippon Express Co Ltd (9062):企業の財務・戦略的SWOT分析
    Nippon Express Co Ltd (9062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sumitomo Corp (8053):企業の財務・戦略的SWOT分析
    Sumitomo Corp (8053) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Virometix AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Virometix AG (Virometix) is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. The company’s pipeline products include prophylactic and therapeutic vaccines for infectious, respiratory, and onc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆